Zedira

Zedira is a clinical stage biotech company specialized in the enzyme class of transglutaminases. Zedira performs drug discovery (e.g. celiac disease, diabetic nephropathy and thromboprophylaxis) and markets specialty reagents for R&D and diagnostics.

Pressemeldungen

Zedira takes diagnostics specialist R-Biopharm on board

As part of a capital increase, R-Biopharm AG has acquired a minority shareholding in Zedira GmbH. With this strategic investment the diagnostics company has secured exclusive access to the celiac disease specialist’s products. High-Tech Gründerfonds has also taken part in the capital increase by investing further…
Read

Info & Contact

Ralf Pasternack
Web:
zedira.com

Address

Roesslerstraße 83
64293 Darmstadt

In portfolio

03. Sep 2007